New Delhi, June 25 -- Navigating the recent market decline has been highly challenging over the last few days. As we head into the late-June expiry, the immediate goal is to break above the crucial resistance barrier at 24,200. Crucial tests lie ahead as traders look for signs of a returning bullish momentum.

Current market price: Rs.2,326.20

Why it's recommended: Gland Pharma is a leading injectable-focused pharmaceutical company with a strong footprint in the US, Europe, Canada, Australia, and key emerging markets. After building a solid base near the Rs.1,600 mark, the stock has been in a sustained uptrend, recently hitting a fresh 52-week high. The current consolidation in the Rs.2,250-2,350 range represents a healthy, temporary pau...